SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-009787
Filing Date
2022-04-13
Accepted
2022-04-13 11:56:08
Documents
16
Period of Report
2022-04-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46711
2 ex99-1.htm EX-99.1 23387
3 ex99-1_001.jpg GRAPHIC 3540
4 ex99-2.htm EX-99.2 903
5 ex99-2_001.jpg GRAPHIC 4384121
  Complete submission text file 0001493152-22-009787.txt   6290446

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE otlc-20220407.xsd EX-101.SCH 3036
7 XBRL LABEL FILE otlc-20220407_lab.xml EX-101.LAB 34476
8 XBRL PRESENTATION FILE otlc-20220407_pre.xml EX-101.PRE 22597
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3293
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 22824116
SIC: 2834 Pharmaceutical Preparations